Found 3 Enz. Inhib. hit(s) with Target = 'Induced myeloid leukemia cell differentiation protein Mcl-1' and Ligand = 'BDBM50552745' TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Janssen Pharmaceutica NV
US Patent
Janssen Pharmaceutica NV
US Patent
Affinity DataKi: 0.200nMAssay Description:The following assay and stock buffers were prepared for use in the assay: (a) Stock buffer: 10 mM Tris-HCl, pH=7.5+150 mM NaCl, filtered, sterilized,...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Janssen Pharmaceutica NV
US Patent
Janssen Pharmaceutica NV
US Patent
Affinity DataKi: 0.210nMAssay Description:The following assay and stock buffers were prepared for use in the assay: (a) Stock buffer: 10 mM Tris-HCl, pH=7.5+150 mM NaCl, filtered, sterilized,...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Homo sapiens (Human))
Janssen Pharmaceutica NV
US Patent
Janssen Pharmaceutica NV
US Patent
Affinity DataKi: 0.210nMAssay Description:Inhibition of Terbium-labeled BIM BH3 peptide binding to MCL1 (unknown origin) incubated for 60 mins by HTRF assayMore data for this Ligand-Target Pair
